OR WAIT null SECS
On the HCPLive gout page, resources on the topics of medical news and expert insight into gouty arthritis can be found. Content includes articles, interviews, videos, podcasts, and breaking news on gout, and more.
April 18, 2024
Article
A propensity score-matched, new-user analysis suggests SGLT2 inhibitors may reduce gout risk in type 2 diabetes patients relative to other second-line therapies.
NSAID use decreased the odds of a cardiovascular event by 12% in patients with gout.
April 17, 2024
Patient-led urate monitoring supports adherence to urate-lowering therapy and helps attain target concentrations among individuals with gout.
April 11, 2024
Alkaline water significantly reduced VAS pain scores among patients with gout.
April 10, 2024
For those with a family history of gout, the proportion of grade ≥ 2 left ventricular diastolic insufficiency was markedly higher compared with patients without family history.
April 08, 2024
Patients with gout who had poor health literacy were more likely to experience ≥ 2 flares within the previous 12 months.
March 29, 2024
Kenneth Saag, MD, explores the clinical significance of a study demonstrating treatment with pegloticase leads to bone remodeling in patients with gout.
March 27, 2024
A meta-analysis found febuxostat was linked to a greater risk for acute coronary syndrome and atrial fibrillation than allopurinol among Asian patients with and without gout.
March 24, 2024
A new review considers how SGLT2 inhibitors like dapagliflozin and empagliflozin have been shown to clinically improve gout while reducing its cardiometabolic and renal comorbidities.
March 22, 2024
Results showed co-administration of methotrexate with pegloticase led to similar rates of urate-lowering response and adverse events in patients with and without CKD.